Health and Fitness Health and Fitness
Tue, November 2, 2010
Mon, November 1, 2010
Sat, October 30, 2010
Fri, October 29, 2010
Thu, October 28, 2010
Wed, October 27, 2010
Tue, October 26, 2010
Mon, October 25, 2010
Sun, October 24, 2010
[ Sun, Oct 24th 2010 ] - Market Wire
Alcon Board Elects New Chairman
Sat, October 23, 2010
Fri, October 22, 2010
Thu, October 21, 2010
Wed, October 20, 2010
[ Wed, Oct 20th 2010 ] - Market Wire
STJ, AGAM, BAC, MDT, BSX
Tue, October 19, 2010
Mon, October 18, 2010
Sun, October 17, 2010
Sat, October 16, 2010
Fri, October 15, 2010
[ Fri, Oct 15th 2010 ] - Market Wire
ALGN, FCN, GOOG, SWY, GCI
Thu, October 14, 2010

Geron Announces Conference Call to Discuss Financial Results for the 2010 Third Quarter


//health-fitness.news-articles.net/content/2010/ .. inancial-results-for-the-2010-third-quarter.html
Published in Health and Fitness on Monday, October 25th 2010 at 13:40 GMT by Market Wire   Print publication without navigation


MENLO PARK, Calif.--([ BUSINESS WIRE ])--Geron Corporation (Nasdaq:GERN) will announce its financial results for the 2010 third quarter on Thursday, October 28, 2010, after the closing of the equity market. Thomas B. Okarma, Ph.D., M.D., Gerona™s president and chief executive officer, and David L. Greenwood, Gerona™s executive vice president and chief financial officer, will host a conference call for analysts and investors on Friday, October 29, 2010 at 8:00 a.m. Pacific Time, 11:00 a.m. Eastern Time.

Participants can access the conference call live via telephone by dialing 866-730-5770 (U.S.); 857-350-1594 (international). The passcode is 14864744. A live audio-only webcast is also available through a link that is posted on the Events page in the Investor Relations section of Gerona™s Web site at [ http://www.geron.com ]. The audio Web broadcast of the conference call will be available for replay within 60 minutes following the live broadcast through November 29, 2010.

Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The company is advancing an anti-cancer drug and a cancer vaccine that target the enzyme telomerase through multiple clinical trials in different cancers. For more information, visit [ www.geron.com ].


Publication Contributing Sources